AZNCF's logo.
Ticker Symbol: AZNCF

Astrazeneca plc

Exchange: OTC MARKETS Country: United Kingdom Currency: USD Asset Type: Common Stock CIK:0000901832

Company Profile

astrazeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. our purpose is to push the boundaries of science to deliver life-changing medicines. we believe the best way we can achieve our purpose is to put science at the centre of everything we do. science defines who we are. it is why we come to work every day and is part of our dna. but this is only half of the story. we know that we do not have all the answers. we want to share ideas because we believe it results in better medicines. we want the way we work to be inclusive, open and collaborative. this approach runs through all that we do. we focus on three main therapy areas – oncology, cardiovascular & metabolic disease (cvmd) and respiratory – and we are also selectively active in the areas of autoimmunity, neuroscience and infection. to put ourselves in the best position to push the boundaries of science, we seek to leverage our combin

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 1 Francis Crick Avenue
CEO: Pascal Soriot
Tags:
  • Pharmaceuticals: Major
  • Health Technology

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $127.86
Change: $0.28 ( 0.22%)
Days Range: $125.95 - $129.25
Beta: -
52wk. High: $153.10
52wk. Low: $104.53
Ytd. Change -4.58%
50 Day Moving Average: $133.83
200 Day Moving Average: $140.94
Shares Outstanding: 1549906100

Valuation

Market Cap: 19.8T
PE Ratio: 64.58
EPS (TTM): 1.98

Dividends

Dividend Per Share (TTM): $2.34
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: August 10, 2023